Prioritize NGS, liquid biopsy, AI-driven interpretation and strategic partnerships to capitalize on precision oncology, companion diagnostics and early detection.Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) ...

Profound advances in breast cancer testing have been made since testing first began in 1996. (HealthDay News) — Women who had genetic testing for inherited cancer risk years ago may want to ask about ...

Limiting inherited genetic testing to younger people with cancer would have missed most of those who carry a cancer-risk gene ...

Healthcare experts at the ETHealthworld India Precision Health & Genomics Leadership Summit 2026 discuss the importance of ...

Next-generation sequencing is widely regarded as a transformative technology that delivers potentially life-prolonging therapies to patients with advanced cancers. Yet the testing is still underused ...

Germline genetic screening can identify whether a patient with cancer has inherited genetic alterations in a gene or genes ...

A new FDA decision and a jump in gene-panel technology are quietly changing what an old “all-clear” really means.

Thousands of women diagnosed with early-stage breast cancer who would once have been sent straight to chemotherapy can now skip it entirely, guided by gene-expression tests that measure the biology of ...

About 5 to 10% of breast cancer cases are linked to inherited gene mutations, which is why doctors recommend all women ...

A randomized trial at MD Anderson Cancer Center found that personalized navigation support raised BRCA genetic testing uptake ...

Your healthcare provider may begin by asking about your symptoms and medical history and performing a clinical breast exam.

Women who had genetic testing for inherited cancer risk years ago may want to ask about testing again, experts say.